Showing 25 to 36 of 100 results
Dutch Cardiology Summit Highlights Underdiagnosis of Heart Disease in Women
A Dutch cardiology summit highlighted the underdiagnosis of heart disease in women, noting that one in five Dutch women die from cardiovascular disease. The summit discussed differences in symptoms between men and women, emphasizing the need for improved diagnosis and treatment.
Dutch Cardiology Summit Highlights Underdiagnosis of Heart Disease in Women
A Dutch cardiology summit highlighted the underdiagnosis of heart disease in women, noting that one in five Dutch women die from cardiovascular disease. The summit discussed differences in symptoms between men and women, emphasizing the need for improved diagnosis and treatment.
Progress
16% Bias Score
ADHD Rise: Increased Awareness, Not Necessarily More Cases
A new analysis suggests the recent rise in ADHD diagnoses may be due to increased awareness rather than a true increase in prevalence, although long-term increases are likely due to a combination of factors including improved detection and changes in diagnostic criteria.
ADHD Rise: Increased Awareness, Not Necessarily More Cases
A new analysis suggests the recent rise in ADHD diagnoses may be due to increased awareness rather than a true increase in prevalence, although long-term increases are likely due to a combination of factors including improved detection and changes in diagnostic criteria.
Progress
40% Bias Score
ADHD Diagnosis Increase: Awareness or Actual Prevalence?
A new analysis of 40 studies suggests that the recent increase in ADHD diagnoses may be primarily due to increased awareness and diagnostic practices, not a surge in actual cases, although a long-term upward trend remains.
ADHD Diagnosis Increase: Awareness or Actual Prevalence?
A new analysis of 40 studies suggests that the recent increase in ADHD diagnoses may be primarily due to increased awareness and diagnostic practices, not a surge in actual cases, although a long-term upward trend remains.
Progress
40% Bias Score
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
Progress
44% Bias Score
FDA Clears Lumipulse Blood Test for Early Alzheimer's Detection
The FDA cleared Lumipulse, a blood test detecting Alzheimer's amyloid plaques in symptomatic adults over 55, improving early diagnosis and access to new treatments, potentially reducing reliance on expensive and invasive procedures.
FDA Clears Lumipulse Blood Test for Early Alzheimer's Detection
The FDA cleared Lumipulse, a blood test detecting Alzheimer's amyloid plaques in symptomatic adults over 55, improving early diagnosis and access to new treatments, potentially reducing reliance on expensive and invasive procedures.
Progress
44% Bias Score
Biden's Advanced Prostate Cancer Diagnosed After Years Without PSA Test
President Biden's prostate cancer, recently diagnosed with bone metastasis and a Gleason score of 9, was not detected in screenings since his last PSA test in 2014, raising concerns about the timeliness of his medical care.
Biden's Advanced Prostate Cancer Diagnosed After Years Without PSA Test
President Biden's prostate cancer, recently diagnosed with bone metastasis and a Gleason score of 9, was not detected in screenings since his last PSA test in 2014, raising concerns about the timeliness of his medical care.
Progress
56% Bias Score
Four Distinct Autism Subtypes Discovered, Unlocking Targeted Treatments
A Princeton University and Simons Foundation study identified four distinct autism subtypes based on behavior and genetics, impacting diagnosis and treatment; genetic mutations before or after birth affect subtypes, potentially leading to targeted therapies.
Four Distinct Autism Subtypes Discovered, Unlocking Targeted Treatments
A Princeton University and Simons Foundation study identified four distinct autism subtypes based on behavior and genetics, impacting diagnosis and treatment; genetic mutations before or after birth affect subtypes, potentially leading to targeted therapies.
Progress
36% Bias Score
Highly Accurate Blood Test Detects Early-Stage Alzheimer's
A new blood test for Alzheimer's, using amyloid beta 42/40 and p-tau217 proteins, achieves 95% sensitivity and 82% specificity in detecting early symptoms, surpassing invasive tests in convenience and cost-effectiveness, and is FDA-approved.
Highly Accurate Blood Test Detects Early-Stage Alzheimer's
A new blood test for Alzheimer's, using amyloid beta 42/40 and p-tau217 proteins, achieves 95% sensitivity and 82% specificity in detecting early symptoms, surpassing invasive tests in convenience and cost-effectiveness, and is FDA-approved.
Progress
36% Bias Score
Jessie J Announces Early Breast Cancer Diagnosis
Singer Jessie J, 37, revealed an early breast cancer diagnosis on Instagram, planning surgery after a London performance later this month; she shared this to process her feelings and connect with others facing similar challenges, highlighting the importance of early detection and open communication.
Jessie J Announces Early Breast Cancer Diagnosis
Singer Jessie J, 37, revealed an early breast cancer diagnosis on Instagram, planning surgery after a London performance later this month; she shared this to process her feelings and connect with others facing similar challenges, highlighting the importance of early detection and open communication.
Progress
28% Bias Score
3D-Printed Pen Shows Promise in Parkinson's Diagnosis
A new 3D-printed pen containing magnetic ink and sensors can identify Parkinson's disease with 96.22% accuracy in a small study by analyzing handwriting, offering a cost-effective and accessible diagnostic tool, especially in lower-income countries.
3D-Printed Pen Shows Promise in Parkinson's Diagnosis
A new 3D-printed pen containing magnetic ink and sensors can identify Parkinson's disease with 96.22% accuracy in a small study by analyzing handwriting, offering a cost-effective and accessible diagnostic tool, especially in lower-income countries.
Progress
20% Bias Score
FDA Approves First Blood Test for Alzheimer's
The FDA approved a new blood test for Alzheimer's disease, increasing diagnostic accuracy to over 90% and improving access to treatment, particularly for those in underserved areas.
FDA Approves First Blood Test for Alzheimer's
The FDA approved a new blood test for Alzheimer's disease, increasing diagnostic accuracy to over 90% and improving access to treatment, particularly for those in underserved areas.
Progress
44% Bias Score
FDA-Approved Blood Test Revolutionizes Alzheimer's Diagnosis in Greece
The FDA-approved Lumipulse blood test, now available at the Ionian University's laboratory in Greece, offers a highly accurate, non-invasive method for diagnosing Alzheimer's disease, impacting 35 million individuals globally and potentially accelerating treatment.
FDA-Approved Blood Test Revolutionizes Alzheimer's Diagnosis in Greece
The FDA-approved Lumipulse blood test, now available at the Ionian University's laboratory in Greece, offers a highly accurate, non-invasive method for diagnosing Alzheimer's disease, impacting 35 million individuals globally and potentially accelerating treatment.
Progress
16% Bias Score
Showing 25 to 36 of 100 results